GREM2 is associated with human central obesity and inhibits visceral preadipocyte browning.

EBioMedicine · 2022 · PMC8965169 · PMID 35349825

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In each BMI category (BMI≤24·0, 24·0–28·0 or ≥28·0 kg/m 2 ), according to the overweight/obesity criteria for China, 32 subjects with higher WC had higher GREM2 levels; whereas, in the subgroup with central obesity, serum GREM2 levels showed a decreasing trend in three BMI categories ( Figure 1 e).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.